Pfizer Inc. recalls MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer…
Labeling: Incorrect or Missing Lot and/or Exp Date: The carton and bottle labels state an expiry date of March 2026; the correct expiration date is February 2025.
Read the official notice →- Date
- 2023-04-19
- Country
- United States
- Brand
- Pfizer
- Product
- MEKTOVI (binimetinib) tablets, 15 mg, 180-count bottle, Rx only, Distributed by: Array BioPharma Inc., a wholly owned subsidiary of Pfizer…
- Classification
- Class III
- Units
- Nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Pfizer recalls
- 2024-01-31
US- 2024-01-24
- US
Pfizer Inc. recalls 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL…
Presence of Particulate Matter; identified as glass
- 2023-11-15
- US
Pfizer Inc. recalls 2% Lidocaine HCl Injection, USP, 100mg/5mL(20mg/mL), Glass ABBOJECT Unit of Use Syringe, packaged as 1 vial and injector per carton, Rx…
Presence of Particulate Matter: identified as glass.
FDA · DrugPfizer Inc.Nationwide in the US and Puerto Rico. The products were not distributed to…Official notice → - 2023-02-01
- US
Pfizer Inc. recalls Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only,…
Presence of Particulate Matter: Glass particulate matter detected in injectable.
- 2023-01-11
- US
Pfizer Inc. recalls Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC…
Lack of assurance of sterility: Bags have the potential to leak.
- 2022-10-12
- US
Pfizer Inc. recalls Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL…
Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
Other drugs & medical recalls in the United States
- 2023-04-19
- US
Church & Dwight Inc recalls Easy Read App associated with First Response Pregnancy Test Sticks - Intended use of converting analog pregnancy test results into text…
Church & Dwight First Response Pregnancy Kits was marketed with the Easy Read App without a new 510k. There is also a potential for Easy Read App to be unable to reads the test results (i.e., no results reported on the…
- US
Fresenius Kabi USA, LLC recalls Ivenix Infusion System (IIS), Large Volume Pump, Model No. LVP-0004
Fluid ingress that can cause a loss of electrical funtion and failure of the Set ID Sensory, resulting in the prevention of infusion or halt of infusion.
FDA · DeviceFresenius Kabi USA, LLCDomestic: CA, CO, NJ, WI, & UT. No foreign distribution.Official notice → - US
Focus Health Group Inc recalls Epinephrine Professional EMS, Epinephrine Convenience Kit, Epinephrine 1 mg/mL, Rx Only, Focus Health Group, Manufactured for: Focus…
Labeling; Incorrect NDC number on outer carton of product.
- US
Pine Pharmaceuticals, LLC recalls Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled…
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.
- US
- US
SUN PHARMACEUTICAL INDUSTRIES INC recalls Norepinephrine Bitartrate Injection, USP, 4 mg/4 mL* (1 mg/mL), 4 mL Single-dose Fliptop Vial (NDC 47335-615-40); packaged in…
Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring.